Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Neerhof MG et al. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. 2012 Reprod Sci pmid:22534337
Kim HA et al. Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis. 2012 Eur. J. Cancer pmid:21889331
Akbarshahi H et al. Acute lung injury in acute pancreatitis--awaiting the big leap. 2012 Respir Med pmid:22749752
Cingi C et al. The histopathological effect of thymoquinone on experimentally induced rhinosinusitis in rats. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185737
Saihkay HN et al. Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. 2011 Jan-Feb J Pharmacol Toxicol Methods pmid:20646985
Lenshof A and Laurell T Emerging clinical applications of microchip-based acoustophoresis. 2011 J Lab Autom pmid:22093301
Michelotto PV et al. Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. 2011 Vet. J. pmid:22108190
Nasopoulou C et al. Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. 2011 Lipids Health Dis pmid:22087726
Sánchez FA et al. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. 2011 J. Biol. Chem. pmid:21757745
Dombrowsky H et al. Ingestion of (n-3) fatty acids augments basal and platelet activating factor-induced permeability to dextran in the rat mesenteric vascular bed. 2011 J. Nutr. pmid:21775525
Tsuda M et al. Platelet-activating factor and pain. 2011 Biol. Pharm. Bull. pmid:21804199
Chan MV et al. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. 2011 Platelets pmid:21806492
Zhou X and He P Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca²⁺]i, nitric oxide, and gap formation in intact venules. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21873500
Alarcón P et al. D-lactic acid interferes with the effects of platelet activating factor on bovine neutrophils. 2011 Vet. Immunol. Immunopathol. pmid:21816488
Machado GB et al. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. 2011 Respir. Res. pmid:21819560
Drolet AM et al. Platelet-activating factor induces Th17 cell differentiation. 2011 Mediators Inflamm. pmid:22013287
Janakiram NB et al. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. 2011 Cancer Metastasis Rev. pmid:22015691
Verouti SN et al. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. 2011 Atherosclerosis pmid:21920519
Yu Y et al. Homosecoiridoids from the flower buds of Lonicera japonica. 2011 J. Nat. Prod. pmid:21942812
Ajiro Y et al. Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21949111
Ma J et al. ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa. 2011 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:21960521
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Tsantila N et al. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. 2011 Angiology pmid:20805097
Rastogi P et al. Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. 2011 Urology pmid:21094990
Uriarte SM et al. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. 2011 J. Immunol. pmid:21642540
Zong RK and Liu J [Effects of Chinese herbal medicine Xinfeng Capsule on expressions of platelet-activating factor and interleukins 6 and 17 in peripheral blood of rats with adjuvant arthritis]. 2011 Zhong Xi Yi Jie He Xue Bao pmid:22152774
Frelinger AL et al. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. 2011 Thromb. Haemost. pmid:21713327
Smit JJ et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. 2011 PLoS ONE pmid:22194949
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Semini G et al. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. 2011 Pharmacogenet. Genomics pmid:21681147
Khan BQ and Kemp SF Pathophysiology of anaphylaxis. 2011 Curr Opin Allergy Clin Immunol pmid:21659865
Parrill AL et al. Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. 2011 BMC Biochem. pmid:22177013
Lacy P et al. Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. 2011 Int. Arch. Allergy Immunol. pmid:21576984
Howard KM et al. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways. 2011 Inflamm. Res. pmid:21432021
Jönsson F et al. Mouse and human neutrophils induce anaphylaxis. 2011 J. Clin. Invest. pmid:21436586
Côrte-Real R et al. The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus. 2011 J. Insect Physiol. pmid:21439293
Li XJ et al. [Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance]. 2011 Zhonghua Bing Li Xue Za Zhi pmid:21426810
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Xu LF et al. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. 2011 Arch. Pharm. Res. pmid:21380808
Aktan I et al. PKC isoenzymes in equine platelets and stimulus induced activation. 2011 Vet. Immunol. Immunopathol. pmid:21513989
Jiang W et al. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro]. 2011 Zhonghua Fu Chan Ke Za Zhi pmid:22333285
Kang NI et al. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock. 2011 J. Immunol. pmid:21531890
Tang WZ et al. Dimeric prenylated C6-C3 compounds from the stem bark of Illicium oligandrum. 2011 J. Nat. Prod. pmid:21524101
Ma SG et al. Four new phenolic diglycosides from the roots of Illicium oligandrum. 2011 Carbohydr. Res. pmid:21524732
Yang AP and Chen Q [Correlation between blood-stasis tongue figure and platelet activating factor (PAF) and acetyl hydrolase of PAF (PAF-AH) in patients with primary dysmenorrhea]. 2011 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:21485072
McHowat J et al. Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung. 2011 Am. J. Physiol., Cell Physiol. pmid:21228317
Orlando RC et al. Esophageal disease: updated information on inflammation. 2011 Ann. N. Y. Acad. Sci. pmid:21950828
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Fang W et al. Platelet activating factor induces blood brain barrier permeability alteration in vitro. 2011 J. Neuroimmunol. pmid:20870297
Fragel-Madeira L et al. Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition. 2011 PLoS ONE pmid:21298035
Garland RC et al. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. 2011 FASEB J. pmid:21257713
Mushtaq N et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. 2011 J. Allergy Clin. Immunol. pmid:21247619
Singh TP et al. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. 2011 Am. J. Pathol. pmid:21281802
Metz M and Maurer M Rupatadine for the treatment of allergic rhinitis and urticaria. 2011 Expert Rev Clin Immunol pmid:21162645
Cureton EL et al. Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. 2011 J. Appl. Physiol. pmid:21183623
Liu J et al. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. 2011 Circ. Res. pmid:21183738
Soares PM et al. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. 2011 Cancer Chemother. Pharmacol. pmid:21153821
Zimmermann LT et al. Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus. 2011 Parasitol. Res. pmid:21161276
Musto AE and Samii M Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. 2011 Epilepsia pmid:21204830
Liao HJ et al. Two new ginkgolides from the leaves of Ginkgo biloba. 2011 Planta Med. pmid:21614751
Penna C et al. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. 2011 Exp. Biol. Med. (Maywood) pmid:21378031
Brooks AC et al. CXCL8 attenuates chemoattractant-induced equine neutrophil migration. 2011 Vet. Immunol. Immunopathol. pmid:21040981
Greiner C et al. 2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo. 2011 Br. J. Pharmacol. pmid:21506958
Lowry P 1-O-alkenyl-sn-glyceryl-3-phosphorylcholine may be a novel posttranslational modification used by the placenta. 2011 Biopolymers pmid:20564011
Kennedy MA et al. Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor. 2011 PLoS Genet. pmid:21347278
Kim HA et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression. 2011 Cell. Physiol. Biochem. pmid:21325822
Ha SW and Lee CS Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. 2010 May-Jun Neurochem. Int. pmid:20304020
Michelotto PV et al. Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. 2010 Mar-Apr J. Vet. Intern. Med. pmid:20102491
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Ciprandi G and Cirillo I Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. 2010 Apr-Jun J. Biol. Regul. Homeost. Agents pmid:20487631
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Kordan W et al. Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. 2010 Pol J Vet Sci pmid:21370733
Xu CL et al. [Inhibitory effect of TBN on platelet aggregation in rabbit]. 2010 Zhong Yao Cai pmid:21243778
Chen S et al. [Induction effect of platelet-activating factor on Src-suppressed C kinase substrate gene expression in rat pulmonary microvascular endothelial cells]. 2010 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:20367900
Leoni G et al. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. 2010 Br. J. Pharmacol. pmid:20331604
Danker K et al. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane. 2010 Br. J. Pharmacol. pmid:20331609
Kajiwara N et al. Activation of human mast cells through the platelet-activating factor receptor. 2010 J. Allergy Clin. Immunol. pmid:20392487
Corl CM et al. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. 2010 Vet. Immunol. Immunopathol. pmid:20359754
Shi C et al. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. 2010 Neurochem. Int. pmid:20362023
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Ritter JM Novel targets and regulatory ordeal by QT interval. 2010 Br J Clin Pharmacol pmid:20406216
Donado E et al. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. 2010 Br J Clin Pharmacol pmid:20406224
Saad MM et al. Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. 2010 Can J Anaesth pmid:19882198
Chen H et al. Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. 2010 Clin Oral Investig pmid:19826843
Sreevidya CS et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. 2010 J. Invest. Dermatol. pmid:19829299
Balestrieri ML et al. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. 2010 Biochim. Biophys. Acta pmid:20637897
Karasuyama H et al. Role for basophils in systemic anaphylaxis. 2010 Chem Immunol Allergy pmid:20519883
Sanz ML et al. In vitro diagnosis of anaphylaxis. 2010 Chem Immunol Allergy pmid:20519886
Sharma J et al. Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. 2010 Biochemistry pmid:20521843
Cerkiene Z et al. Immune factors in human embryo culture and their significance. 2010 Medicina (Kaunas) pmid:20571290
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
Liu SH et al. Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide. 2010 Chin. Med. J. pmid:20497711
Kuebler WM et al. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. 2010 Cell. Physiol. Biochem. pmid:20502002
Wang L et al. Three new compounds from Morus nigra L. 2010 J Asian Nat Prod Res pmid:20552479
Lu J et al. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. 2010 Pediatr. Res. pmid:20531249
Kim DD et al. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. 2010 Microcirculation pmid:20163539
Grassi G et al. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. 2010 J. Endocrinol. Invest. pmid:20220291
Binder U et al. The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. 2010 Mol. Microbiol. pmid:19889092
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Peng SY et al. [Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes]. 2010 Yao Xue Xue Bao pmid:21351565